Trial intelligence / Profile preview

Oral ibuprofen vs intravenous indomethacin for treatment of patent ductus arteriosus

IRCT2015111024977N1Phase 3Completed

Sponsor
Qom University of Medical Sciences
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ibuprofen and indomethacin in patent ductus arteriosus (PDA) (2 arms), sponsored by Qom University of Medical Sciences. Started Aug 2014; status: completed.

02

Drugs

ibuprofenindomethacin
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on IRCT2015111024977N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015111024977N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call